City
Epaper

Happy moment for India: Congress on Covaxin getting EUL from WHO

By ANI | Updated: November 3, 2021 22:45 IST

After Covaxin got emergency use listing approval from the World Health Organisation (WHO), Congress leader Sandeep Dikshit on Wednesday said that the nod was a happy moment for India as travellers faced difficulties earlier without the approval of the vaccine.

Open in App

After Covaxin got emergency use listing approval from the World Health Organisation (WHO), Congress leader Sandeep Dikshit on Wednesday said that the nod was a happy moment for India as travellers faced difficulties earlier without the approval of the vaccine.

Talking to ANI, Dikshit said, "It is a matter of relief and we have been using the vaccine (Covaxin), but it did not get permission, so the travellers faced difficulties. But now, they will not face issues and it is a happy moment for India."

The WHO on Wednesday granted emergency use listing (EUL) to Covaxin adding to a growing portfolio of vaccines validated by WHO for prevention of COVID-19.

The WHO said in a tweet that the Technical Advisory Group, convened by World Health Organisation (WHO), has determined that the Hyderabad-based Bharat Biotech's COVID-19 vaccine meets WHO standards for protection against COVID-19.

"WHO has granted emergency use listing (EUL) to COVAXIN® (developed by Bharat Biotech), adding to a growing portfolio of vaccines validated by WHO for the prevention of #COVID19," WHO said in a tweet.

"The Technical Advisory Group, convened by WHO and made up of regulatory experts from around the world, has determined that the Covaxin vaccine meets WHO standards for protection against #COVID19, that the benefit of the vaccine far outweighs risks and the vaccine can be used," it added.

The global health body said that the Covaxin vaccine was also reviewed by WHO's Strategic Advisory Group of Experts on Immunization (SAGE), and recommended the use of this vaccine in two doses, with a dose interval of four weeks, in all age groups 18 and above.

"Available data on vaccination of pregnant women with the Covaxin vaccine is insufficient to assess vaccine safety or efficacy in pregnancy; studies in pregnant women are planned, including a pregnancy sub-study and a pregnancy registry," WHO said.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: congressSandeep DikshitWorld Health Organisation
Open in App

Related Stories

NationalPahalgam Terror Attack: Rahul Gandhi Cuts Short US Visit, To Attend CWC Meeting in New Delhi

Navi MumbaiNavi Mumbai: Eknath Shinde’s Strategy to Give Strength to BJP; 12 Former Corporators Likely To Join Shiv Sena

NationalRahul Gandhi Urges States to Enact Rohith Vemula Act to End Caste Discrimination in Education

NationalNational Herald Case: Congress Party Workers Detained in Protest Over ED Targeting Sonia & Rahul Gandhi (Watch Video)

NationalMallikarjun Kharge Responds to PM Modi’s Allegations, Defends Congress role in Ambedkar Legacy (Watch Video)

National Realted Stories

National'Terror will never win': Former UK PM Rishi Sunak condemns terrorist attack in J&K's Pahalgam

NationalPahalgam terror attack: Antigua PM writes to PM Modi; extends condolences

NationalED attaches Sahara's 'benami' properties valued at Rs 1,538 crore across India

NationalUN chief strongly condemns Pahalgam terror attack

National'Cowardly act against Humanity': Dilip Jaiswal deplores Pahalgam terror attack